as 01-21-2025 4:00pm EST
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).
Founded: | 1892 | Country: | United States |
Employees: | N/A | City: | CHICAGO |
Market Cap: | 36.2B | IPO Year: | N/A |
Target Price: | $96.00 | AVG Volume (30 days): | 3.2M |
Analyst Decision: | Buy | Number of Analysts: | 14 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 3.65 | EPS Growth: | 8.27 |
52 Week Low/High: | $71.31 - $94.55 | Next Earning Date: | 02-13-2025 |
Revenue: | $19,559,000,000 | Revenue Growth: | 1.43% |
Revenue Growth (this year): | 2.7% | Revenue Growth (next year): | 3.90% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Rott Roland | GEHC | CEO, Imaging | Nov 5 '24 | Sell | $86.48 | 3,577 | $309,338.96 | 24,298 | |
Rackliffe Philip | GEHC | CEO, AVS | Nov 5 '24 | Sell | $87.63 | 900 | $78,867.00 | 12,715 |
GEHC Breaking Stock News: Dive into GEHC Ticker-Specific Updates for Smart Investing
Simply Wall St.
10 hours ago
Business Wire
6 days ago
Business Wire
7 days ago
Argus Research
8 days ago
Simply Wall St.
8 days ago
Simply Wall St.
18 days ago
TipRanks
19 days ago
Simply Wall St.
24 days ago
The information presented on this page, "GEHC GE HealthCare Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.